How is Mesothelioma Diagnosed? The Complete Diagnostic Process

Diagnostic Challenges

Mesothelioma is notoriously difficult to diagnose for several reasons:

• Rarity: Doctors may not immediately consider mesothelioma due to its uncommon nature
• Symptom overlap: Symptoms mimic more common conditions like pneumonia, lung cancer, or irritable bowel syndrome
• Long latency: The 20-50 year gap between exposure and symptoms makes the connection difficult
• Microscopic similarity: Mesothelioma cells can resemble other cancer cells under examination

These challenges mean the diagnostic process often takes weeks or months, requiring multiple tests and specialist consultations.

Imaging Tests

Imaging studies help visualize tumors, determine their location and size, and identify whether cancer has spread.

X-Ray

Often the first imaging test performed when patients present with respiratory symptoms. X-rays can reveal:

• Pleural effusion (fluid around the lungs)
• Thickening of the pleura
• Masses or abnormal densities
• Calcified pleural plaques (evidence of asbestos exposure)

While useful as an initial screening tool, X-rays cannot definitively diagnose mesothelioma.

CT Scan (Computed Tomography)

CT scans provide detailed cross-sectional images and are the primary imaging tool for mesothelioma diagnosis and staging.

• Detects smaller tumors not visible on X-ray
• Determines tumor location and extent
• Identifies enlarged lymph nodes
• Guides biopsy procedures
• Assesses whether cancer has spread to other organs

Patients typically receive contrast dye intravenously to enhance image clarity.

MRI (Magnetic Resonance Imaging)

MRI uses magnetic fields rather than radiation to create detailed images, particularly useful for:

• Evaluating tumor invasion into chest wall, diaphragm, or spine
• Assessing whether tumors involve major blood vessels
• Surgical planning by defining tumor boundaries
• Differentiating between benign and malignant tissue in some cases

PET Scan (Positron Emission Tomography)

PET scans use radioactive glucose to identify areas of high metabolic activity, which may indicate cancer.

• Detects cancer spread to lymph nodes and distant organs
• Helps determine cancer stage
• Differentiates between scar tissue and active cancer
• Evaluates treatment effectiveness

PET-CT combines both technologies, providing both functional (PET) and anatomical (CT) information in a single scan.

Echocardiogram

An ultrasound of the heart used to evaluate pericardial mesothelioma or assess heart function when pleural mesothelioma may affect cardiac performance.

Biopsy Procedures

A biopsy—removing tissue samples for laboratory analysis—is the only definitive way to diagnose mesothelioma. Several biopsy methods exist depending on tumor location.

Thoracoscopy / VATS (Video-Assisted Thoracic Surgery)

The preferred method for obtaining pleural mesothelioma samples:

• Small incision made between the ribs
• Camera and instruments inserted into chest cavity
• Direct visualization of tumors
• Multiple tissue samples obtained
• Fluid can be drained if present
• Talc pleurodesis can be performed to prevent fluid recurrence

This procedure is performed under general anesthesia and typically requires a 1-3 day hospital stay.

Thoracentesis

A simpler procedure that removes fluid from the pleural space:

• Needle inserted between ribs into fluid collection
• Fluid drained for analysis
• Can relieve breathing difficulties
• Fluid cytology may detect cancer cells

However, fluid alone often doesn't provide enough cells for definitive diagnosis, and tissue biopsy is usually still required.

Needle Biopsy (Core Needle or Fine Needle Aspiration)

Image-guided needle biopsies using CT or ultrasound guidance:

• Less invasive than surgical biopsy
• May not obtain sufficient tissue for complete analysis
• Risk of sampling error (missing the cancerous area)

Laparoscopy

Similar to thoracoscopy but for abdominal (peritoneal) mesothelioma:

• Camera inserted through small abdominal incision
• Direct visualization of abdominal cavity
• Multiple biopsies obtained
• Assessment of tumor extent and resectability

Mediastinoscopy

Procedure to sample lymph nodes in the mediastinum (center of chest):

• Small incision at base of neck
• Scope inserted to access lymph nodes
• Determines if cancer has spread to lymph nodes
• Critical for accurate staging

Lumbar Puncture (Spinal Tap)

Lumbar puncture may be performed to check for cancer cells in cerebrospinal fluid, particularly when CNS involvement is suspected or to assess metastatic spread.

Surgical Biopsy

Open surgical procedures may be necessary when less invasive methods cannot obtain adequate tissue.

Blood Tests and Biomarkers

While no blood test can definitively diagnose mesothelioma, several biomarkers help support diagnosis and monitor treatment.

Mesomark (SMRP - Soluble Mesothelin-Related Peptides)

• Elevated in many mesothelioma patients
• Higher levels often correlate with more advanced disease
• Can monitor treatment response
• May rise before imaging shows progression

However, SMRP can also be elevated in other cancers and some non-cancerous conditions.

Osteopontin

Another biomarker that may be elevated in mesothelioma, though less specific than SMRP.

Fibulin-3

Early research suggested fibulin-3 could distinguish mesothelioma patients from those with other pleural diseases, though clinical utility remains limited.

HMGB1 (High Mobility Group Box 1)

Emerging biomarker showing promise for distinguishing mesothelioma from asbestos-related benign conditions.

Important note: Biomarker tests alone cannot diagnose mesothelioma but provide supporting information alongside imaging and biopsy results.

Pathology and Cell Types

Pathologists examine biopsy samples under microscopes to confirm mesothelioma diagnosis and identify cell type—critical information for treatment planning.

Three Main Cell Types

Epithelioid Mesothelioma:

• Most common type (50-70% of cases)
• Cells resemble epithelial tissue
• Best prognosis of the three types
• More likely to respond to treatment

Sarcomatoid Mesothelioma:

• Rarest type (10-15% of cases)
• Spindle-shaped cells resembling sarcoma
• Most aggressive type
• Poorer response to treatment

Biphasic (Mixed) Mesothelioma:

• Contains both epithelioid and sarcomatoid cells
• 20-30% of cases
• Prognosis depends on ratio of cell types
• Higher sarcomatoid component = worse prognosis

Immunohistochemistry (IHC)

This specialized staining technique uses antibodies to detect specific proteins in tissue samples, helping pathologists:

• Confirm mesothelioma versus other cancers
• Determine cell type
• Rule out conditions that resemble mesothelioma

Common markers include calretinin, WT-1, cytokeratin 5/6, and mesothelin. Additionally, tumor grading helps pathologists assess how aggressive the cancer is based on cell appearance and organization.

Cancer Staging

Staging determines how far cancer has spread and guides treatment decisions. Mesothelioma uses different staging systems for pleural and peritoneal types. Once your stage is determined, you can explore appropriate treatment options and connect with experienced mesothelioma specialists.

Pleural Mesothelioma Staging (TNM System)

Stage 1:

• Cancer limited to one side of the chest
• Pleural lining affected
• No lymph node involvement
• Surgery often an option

Stage 2:

• Cancer has spread to nearby lymph nodes on same side
• May involve lung or diaphragm
• Surgery may still be possible

Stage 3:

• Spread to deeper chest tissues
• May involve heart lining or lymph nodes on both sides
• Surgery typically not an option
• Chemotherapy and radiation main treatments

Stage 4:

• Cancer has spread to distant organs
• May be in bones, liver, brain, or other areas
• Treatment focuses on symptom management and quality of life

Peritoneal Mesothelioma Staging

Peritoneal mesothelioma often uses the Peritoneal Cancer Index (PCI), which scores tumor spread across 13 abdominal regions. Lower scores indicate more limited disease and better surgical candidacy.

Getting a Second Opinion

Given the complexity of mesothelioma diagnosis, seeking a second opinion from a specialized cancer center is highly recommended.

Why Second Opinions Matter

• Mesothelioma is rare—most pathologists see few cases
• Specialized centers have more diagnostic experience
• Cell type determination affects treatment decisions
• Different staging assessments may change treatment options

Preparing for a Second Opinion

• Gather all imaging studies (CDs with DICOM files preferred)
• Obtain pathology slides and reports
• Compile complete medical records
• Document work and asbestos exposure history
• Prepare questions about diagnosis and treatment options

Documenting Your Diagnosis for Legal Purposes

Your mesothelioma diagnosis represents medical evidence of asbestos exposure and harm. Proper documentation is essential for pursuing compensation and legal action. Keep organized records of:

• All diagnostic test results and imaging studies
• Pathology reports confirming mesothelioma diagnosis
• Physician notes documenting asbestos exposure history
• Medical records showing symptom onset and progression
• Treatment records and costs

These documents support mesothelioma claims against responsible parties, asbestos trust funds, or workers' compensation. An experienced mesothelioma attorney can guide you through the legal process and help you understand your rights to compensation.